- In October 2023, the FDA granted approval for Cabtreo, a topical gel comprising clindamycin phosphate, adapalene, and benzoyl peroxide, to treat acne vulgaris in patients aged 12 and above. Clindamycin phosphate is an antibiotic that reduces acne-causing bacteria, adapalene is a retinoid that unclogs pores and reduces inflammation, while benzoyl peroxide works by killing bacteria and reducing excess oil production. This combination offers a comprehensive approach to treating acne, targeting multiple factors contributing to its development, and providing a promising option for patients seeking effective skincare solutions
Frequently Asked Questions
The market is segmented based on Segmentation, By Indication (Psoriasis, Dry Skin, Acne Vulgaris, Warts, Dandruff, Others), Dosage Form (Shampoo, Gel, Solution, Face Wash, Lotion, Creams, Others) Agents (Urea, Salicylic AcidLactic Acid, Alpha Hydroxy Acids, Propylene Glycol, Others), End-Users (Hospitals, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Others) – Industry Trends and Forecast to 2031
.
The Global Topical Keratolytics Market size was valued at USD 1.50 USD Billion in 2023.
The Global Topical Keratolytics Market is projected to grow at a CAGR of 5.56% during the forecast period of 2024 to 2031.
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E., South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
